Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1956 1
1958 1
1974 1
1975 1
1976 2
1977 1
1978 1
1979 4
1980 4
1981 5
1982 1
1983 2
1984 4
1985 5
1986 4
1987 5
1988 2
1989 6
1990 7
1991 10
1992 9
1993 4
1994 15
1995 13
1996 12
1997 6
1998 9
1999 7
2000 14
2001 7
2002 8
2003 8
2004 8
2005 6
2006 8
2007 15
2008 20
2009 19
2010 17
2011 20
2012 21
2013 20
2014 18
2015 16
2016 18
2017 20
2018 25
2019 23
2020 25
2021 23
2022 44
2023 41
2024 14

Text availability

Article attribute

Article type

Publication date

Search Results

533 results

Results by year

Filters applied: . Clear all
Page 1
Systemic sclerosis in adults. Part I: Clinical features and pathogenesis.
Jerjen R, Nikpour M, Krieg T, Denton CP, Saracino AM. Jerjen R, et al. J Am Acad Dermatol. 2022 Nov;87(5):937-954. doi: 10.1016/j.jaad.2021.10.065. Epub 2022 Feb 4. J Am Acad Dermatol. 2022. PMID: 35131402 Review.
Recent developments in our understanding of disease-specific autoantibodies and bioinformatic analyses has led to a reconsideration of the purely clinical classification of diffuse and limited cutaneous SSc subgroups. Autoantibody profiles are predictive of skin and intern …
Recent developments in our understanding of disease-specific autoantibodies and bioinformatic analyses has led to a reconsideration of the p …
Extragenital lichen sclerosus: A comprehensive review.
Arif T, Fatima R, Sami M. Arif T, et al. Australas J Dermatol. 2022 Nov;63(4):452-462. doi: 10.1111/ajd.13890. Epub 2022 Aug 11. Australas J Dermatol. 2022. PMID: 35950883 Review.
The relationship with morphoea has been a topic of debate. Association with several autoimmune diseases has been observed. Diagnosis is usually based on clinical and dermoscopic examination and further supported by histopathological findings. ...
The relationship with morphoea has been a topic of debate. Association with several autoimmune diseases has been observed. Diagnosis …
Renal involvement in systemic sclerosis.
Scheen M, Dominati A, Olivier V, Nasr S, De Seigneux S, Mekinian A, Issa N, Haidar F. Scheen M, et al. Autoimmun Rev. 2023 Jun;22(6):103330. doi: 10.1016/j.autrev.2023.103330. Epub 2023 Apr 7. Autoimmun Rev. 2023. PMID: 37031831 Free article. Review.
The spectrum of renal manifestations in systemic sclerosis ranges from an isolated decrease in glomerular filtration rate, increased intrarenal arterial stiffness, and isolated proteinuria due to SRC to more rare manifestations such as association with antiphospholipid antibody n …
The spectrum of renal manifestations in systemic sclerosis ranges from an isolated decrease in glomerular filtration rate, increased intrare …
Scleroderma in children.
Zulian F. Zulian F. Best Pract Res Clin Rheumatol. 2017 Aug;31(4):576-595. doi: 10.1016/j.berh.2018.02.004. Epub 2018 Mar 27. Best Pract Res Clin Rheumatol. 2017. PMID: 29773274 Review.
Juvenile scleroderma with its two varieties, juvenile localized scleroderma and systemic sclerosis (SSc), represents the third most frequent rheumatic disease in childhood. ...In localized scleroderma, the wider application of clinical and instrumental …
Juvenile scleroderma with its two varieties, juvenile localized scleroderma and systemic sclerosis (SSc), represents the third …
European Dermatology Forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes.
Knobler R, Moinzadeh P, Hunzelmann N, Kreuter A, Cozzio A, Mouthon L, Cutolo M, Rongioletti F, Denton CP, Rudnicka L, Frasin LA, Smith V, Gabrielli A, Aberer E, Bagot M, Bali G, Bouaziz J, Braae Olesen A, Foeldvari I, Frances C, Jalili A, Just U, Kähäri V, Kárpáti S, Kofoed K, Krasowska D, Olszewska M, Orteu C, Panelius J, Parodi A, Petit A, Quaglino P, Ranki A, Sanchez Schmidt JM, Seneschal J, Skrok A, Sticherling M, Sunderkötter C, Taieb A, Tanew A, Wolf P, Worm M, Wutte NJ, Krieg T. Knobler R, et al. J Eur Acad Dermatol Venereol. 2017 Sep;31(9):1401-1424. doi: 10.1111/jdv.14458. Epub 2017 Aug 9. J Eur Acad Dermatol Venereol. 2017. PMID: 28792092
The present guideline focuses on characteristic clinical and histopathological features, diagnostic scores and the serum autoantibodies most useful for differential diagnosis. ...Part 1 of this guideline provides clinicians with an overview of the diagnosis and treatment o …
The present guideline focuses on characteristic clinical and histopathological features, diagnostic scores and the serum autoantibodi …
Localized scleroderma.
Kreuter A. Kreuter A. Dermatol Ther. 2012 Mar-Apr;25(2):135-47. doi: 10.1111/j.1529-8019.2012.01479.x. Dermatol Ther. 2012. PMID: 22741933 Review.
To date, there are no specific serological markers available for localized scleroderma. Within the last years, several validated clinical scores have been introduced as potential outcome measures for the disease. Given the rarity of localized sclero
To date, there are no specific serological markers available for localized scleroderma. Within the last years, several validat …
Treatment in Juvenile Scleroderma.
Zulian F, Tirelli F. Zulian F, et al. Curr Rheumatol Rep. 2020 Jun 26;22(8):45. doi: 10.1007/s11926-020-00910-x. Curr Rheumatol Rep. 2020. PMID: 32591919 Review.
RECENT FINDINGS: According to the recent recommendations for Pediatric Rheumatology in Europe (SHARE), systemic treatment in localized scleroderma is needed when there is a risk for disability, such as in generalized or pansclerotic morphea and progressive linear sc …
RECENT FINDINGS: According to the recent recommendations for Pediatric Rheumatology in Europe (SHARE), systemic treatment in localized
Scleroderma in children: an update.
Zulian F, Cuffaro G, Sperotto F. Zulian F, et al. Curr Opin Rheumatol. 2013 Sep;25(5):643-50. doi: 10.1097/BOR.0b013e3283641f61. Curr Opin Rheumatol. 2013. PMID: 23912318 Review.
New developments have been also reached in the field of outcome measures. In juvenile localized scleroderma (JLS), new techniques such as Doppler and laser Doppler imaging have shown their usefulness for the daily monitoring of the patients. In juvenile systemic scl …
New developments have been also reached in the field of outcome measures. In juvenile localized scleroderma (JLS), new techniq …
Localized scleroderma: clinical and epidemiological features with emphasis on adulthood- versus childhood-onset disease differences.
Lis-Święty A, Skrzypek-Salamon A, Ranosz-Janicka I, Brzezińska-Wcisło L. Lis-Święty A, et al. J Eur Acad Dermatol Venereol. 2017 Oct;31(10):1595-1603. doi: 10.1111/jdv.14197. Epub 2017 Apr 3. J Eur Acad Dermatol Venereol. 2017. PMID: 28271552 Review.
BACKGROUND: Localized scleroderma is a rare inflammatory skin disorder that affects the skin and sometimes underlying subcutaneous tissue, muscles or bones. ...Recurrences of disease were independent of its onset mode. aLoS patients had more poor quality of life …
BACKGROUND: Localized scleroderma is a rare inflammatory skin disorder that affects the skin and sometimes underlying subcutan …
Diagnosis and management of morphoea in children: an overview.
Weibel L. Weibel L. Clin Exp Dermatol. 2021 Apr;46(3):487-494. doi: 10.1111/ced.14562. Epub 2021 Mar 10. Clin Exp Dermatol. 2021. PMID: 33751628 Review.
Paediatric morphoea (localized scleroderma) is an inflammatory sclerosing disorder of the skin and subcutis associated with tissue atrophy. ...Extracutaneous manifestations occur in up to 20% of patients, with arthritis/arthralgia and neurological symptoms being mos …
Paediatric morphoea (localized scleroderma) is an inflammatory sclerosing disorder of the skin and subcutis associated with ti …
533 results